You searched for London - Page 28 of 35

Interview 4 Dec 2017

Meet the CEO Leading Italy’s Charge to Become a Major Biotech Player

…Milan could be the next biotech hub in Europe – replicating the likes of Barcelona, Berlin, and London. Progress is being made in Italy, including government investment in the Human…

December 4, 2017 - 7 minutesmins - By Alex Dale

In Depth 15 Feb 2024

Turning the tide: recent advancements in childhood cancer research

…and Cancer – University College London Transfusion of Lifespan-Extended Neutrophils Restores Immune Defenses in Neutropenic Hosts – Boston Children’s Hospital Childhood cancer funding among challenges to battle Although different kinds…

February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 6 Aug 2018

New Gene Therapy Could Treat Cystic Fibrosis With One Dose

…ProQR is developing a drug that binds to mutated RNA of the CFTR gene to restore the production of a healthy CFTR protein. London biotech Verona Pharma recently obtained positive…

August 6, 2018 - 3 minutesmins - By Alexander Burik

Gene therapy genenta science genflow biosciences

News and Trends 21 Jan 2022

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

…in its Nasdaq debut in December 2021 and Genflow Biosciences listed on the London Stock Exchange this week, raising around €4.4M (£3.7M) in the process. One factor driving the general…

January 21, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 16 Jan 2018

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

…discovery technology. The application of AI to drug discovery is a growing trend, especially in the UK. Companies like BenevolentBIO in London and Exscientia in Oxford are already starting to…

January 16, 2018 - 1 minutemin - By Clara Rodríguez Fernández

More News! 17 Jan 2017

Nanoparticles from Car Tailpipes could Activate Viruses in the Lungs

…energy. Last year, the World Health Organization (WHO) reported that 3 million premature deaths can be attributed to air pollution annually. In Europe, London could easily be one of the…

January 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 Apr 2019

Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia

…the patient. The London-based biotech Orchard Therapeutics is developing a gene therapy that could provide a better alternative to current treatments. Acquired from GSK last year, this therapy involves taking…

April 30, 2019 - 3 minutesmins - By Jonathan Smith

In Depth 14 Nov 2017

The World’s Deadliest Diseases: How is Biotech Fighting Them?

…(MSD), GSK with its partner Emergent Biosolutions, and Bavarian Nordic in collaboration with Janssen. Most recently, researchers at St. George’s University of London developed a vaccine which showed to be…

November 14, 2017 - 7 minutesmins - By Ute Boronowsky

Mike Nally Generate Biomedicines ai drug discovery

Interview 12 Oct 2022

Boosting pharma’s falling productivity with AI in drug discovery

…the decades, the pharma and biopharma industry has suffered a growing stagnation in productivity. According to a report from University College London in 2018, for example, the number of new…

October 12, 2022 - 5 minutesmins - By Jonathan Smith

In Depth 17 Jul 2025

New horizons in sickle cell disease treatment: Promising therapies on the way

…on the National Health Service (NHS) at specialist NHS centres in London, Manchester and Birmingham, which will go a long way to helping many people regain control over their lives …

July 17, 2025 - 9 minutesmins - By Willow Shah-Neville

granulomatous disease orchard therapeutics

News and Trends 18 Dec 2017

British Biotech Takes Over Development of Gene Therapy for Rare Immune Disease

Orchard Therapeutics has licensed a gene therapy for the rare genetic disorder X-linked chronic granulomatous disease (X-CGD) from the non-profit Généthon. London-based Orchard Therapeutics is adding a new program to…

December 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 18 May 2018

New Treatment for Rare Neurologic Eye Disease on Horizon from Spanish Biotech

…in humans in a Phase I trial in London. It has already been granted ‘orphan’ status for optic neuritis in Europe and the United States. It works by triggering young…

May 18, 2018 - 2 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: London

Meet the CEO Leading Italy’s Charge to Become a Major Biotech Player

Turning the tide: recent advancements in childhood cancer research

New Gene Therapy Could Treat Cystic Fibrosis With One Dose

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

Nanoparticles from Car Tailpipes could Activate Viruses in the Lungs

Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia

The World’s Deadliest Diseases: How is Biotech Fighting Them?

Boosting pharma’s falling productivity with AI in drug discovery

New horizons in sickle cell disease treatment: Promising therapies on the way

British Biotech Takes Over Development of Gene Therapy for Rare Immune Disease

New Treatment for Rare Neurologic Eye Disease on Horizon from Spanish Biotech

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!